Filing Details

Accession Number:
0001567619-19-008667
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-10 16:06:23
Reporting Period:
2019-04-08
Accepted Time:
2019-04-10 16:06:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1398659 Genpact Ltd G Services-Management Consulting Services (8742) 980533350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1408239 V. N. Tyagarajan C/O Genpact Llc
1155 Avenue Of The Americas, 4Th Floor
New York NY 10036
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2019-04-08 150,000 $9.52 633,891 No 4 M Direct
Common Shares Disposition 2019-04-08 150,000 $35.37 483,891 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Employee Stock Option (Right to Buy) Disposition 2019-04-08 150,000 $0.00 150,000 $9.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
133,625 2019-05-06 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 10,000 Indirect By Trust
Footnotes
  1. The exercise price reflects an adjustment that was made to preserve the value of the reporting person's outstanding stock options following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012.
  2. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $35.045 to $35.59. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein.
  4. The?option?vested?20%?annually?over?5?years?beginning?on May?1,?2010.
  5. The number of derivative securities beneficially owned reflects an adjustment that was made to preserve the value of the reporting person's outstanding stock options following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012.